Evaluating ReX for managing solid oral medications
Non-randomized Observational Study to Collate Data Regarding the Safety, Efficacy and Satisfaction of ReX® in the Management of Solid Oral Medications.
This study is testing if the ReX Remote Digital Nurse can help people safely take their oral medications and feel satisfied with the process over 24 weeks.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Dosentrx Ltd. Industry-sponsored |
| Locations | 1 site (Cincinnati, Ohio) |
| Trial ID | NCT06335758 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the safety, efficacy, and patient satisfaction of the ReX Remote Digital Nurse in managing solid oral medications. Participants will receive their standard oral medications through the ReX device, which dispenses pills and monitors adherence via a touch screen interface. The study will track treatment duration, adverse events, and patient engagement through electronic patient-reported outcomes over a 24-week period. Data will be collected through questionnaires and phone calls to evaluate the overall effectiveness of the ReX platform.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are prescribed oral medications and can effectively use the ReX device.
Not a fit: Patients with significant physical disabilities or cognitive impairments that hinder their ability to use the ReX device may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance medication adherence and patient satisfaction for those taking solid oral medications.
How similar studies have performed: While the ReX platform is a novel approach, similar studies evaluating digital health interventions for medication management have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 18 years of age or older. 2. Care team recommends the use of ReX as a standard of care. 3. Patients have 5th grade reading level. 4. Patient was prescribed oral medication. 5. Patient takes medication at home. Exclusion Criteria: 1. Patient has significant physical disability including poor fine motor skills, impaired visual or auditory faculties, mental disorders or other impairment affecting ability to provide Informed Consent or use the ReX dispensing unit effectively. 2. Patient failed to pass the learning module during ReX onboarding flow. 3. Patient is at end stage or terminal illness with anticipated life expectancy of 6 months or less.
Where this trial is running
Cincinnati, Ohio
- Ohc — Cincinnati, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: David Waterhouse, MD — US Oncology
- Study coordinator: Natan Paz
- Email: natan.p@dosentrx.com
- Phone: +972 52 6577126
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.